mifepristone has been researched along with ru 43044 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hansen, PJ; Monterroso, VH | 1 |
De Bosscher, K; Francesconi, E; Haegeman, G; Resche-Rigon, M; Vanden Berghe, W | 1 |
Archer, TK; Fryer, CJ; Garabedian, MJ; Kinyamu, HK; Rogatsky, I | 1 |
Benhamou, B; Gofflo, D; Guillot, B; Moras, D; Ossart, C; Philibert, D; Robin-Jagerschmidt, C; Vergezac, A; Wurtz, JM | 1 |
Belikov, S; Gelius, B; Wrange , O | 1 |
5 other study(ies) available for mifepristone and ru 43044
Article | Year |
---|---|
Regulation of bovine and ovine lymphocyte proliferation by progesterone: modulation by steroid receptor antagonists and physiological status.
Topics: Animals; Cattle; Dose-Response Relationship, Drug; Drug Synergism; Female; Glucocorticoids; Hydroxycorticosteroids; Lactation; Lymphocyte Activation; Mifepristone; Osmolar Concentration; Progesterone; Receptors, Steroid; Sheep | 1993 |
Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism.
Topics: Animals; Anti-Inflammatory Agents; DNA; DNA-Binding Proteins; Gene Expression Regulation; Genes, Reporter; Glucocorticoids; HeLa Cells; Hormone Antagonists; Humans; Hydroxycorticosteroids; I-kappa B Proteins; Interleukin-6; Mice; Mifepristone; NF-kappa B; NF-KappaB Inhibitor alpha; Promoter Regions, Genetic; Trans-Activators; Transcription Factor AP-1; Transcription, Genetic; Transcriptional Activation; Tumor Cells, Cultured | 1999 |
Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells.
Topics: Animals; Breast Neoplasms; Dexamethasone; Female; Gene Expression Regulation, Neoplastic; Glucocorticoids; Hormone Antagonists; Humans; Hydroxycorticosteroids; Mammary Tumor Virus, Mouse; Mice; Mifepristone; Osteosarcoma; Promoter Regions, Genetic; Receptors, Glucocorticoid; Transcription, Genetic; Tumor Cells, Cultured | 2000 |
Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity.
Topics: Amino Acid Sequence; Animals; Base Sequence; Binding Sites; Furylfuramide; Glucocorticoids; Hormone Antagonists; Humans; Hydroxycorticosteroids; Mifepristone; Models, Molecular; Molecular Sequence Data; Progestins; Promegestone; Protein Conformation; Receptors, Glucocorticoid; Receptors, Progesterone; Recombinant Proteins; Sequence Homology, Amino Acid; Substrate Specificity; Transcriptional Activation | 2000 |
Hormone-induced nucleosome positioning in the MMTV promoter is reversible.
Topics: Animals; Chromatin; Female; Glucocorticoids; Hormone Antagonists; Hydroxycorticosteroids; Mammary Tumor Virus, Mouse; Mice; Mifepristone; Nucleosomes; Oocytes; Promoter Regions, Genetic; Protein Biosynthesis; Rats; Receptors, Glucocorticoid; Recombinant Proteins; Transcription, Genetic; Xenopus laevis | 2001 |